Market revenue in 2023 | USD 764.7 million |
Market revenue in 2030 | USD 1,463.0 million |
Growth rate | 9.7% (CAGR from 2023 to 2030) |
Largest segment | Pharmaceuticals |
Fastest growing segment | Biologics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biologics, Pharmaceuticals, Medicated Feed Additives |
Key market players worldwide | Zoetis Inc Class A, Boehringer Ingelheim, Merck & Co Inc, Elanco Animal Health Inc, Dechra Pharmaceuticals, Ceva Santé Animale, Phibro Animal Health Corp Class A, Virbac SA, Bimeda Ireland, Biogenesis Bago |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary medicine market will help companies and investors design strategic landscapes.
Pharmaceuticals was the largest segment with a revenue share of 67.73% in 2023. Horizon Databook has segmented the Argentina veterinary medicine market based on biologics, pharmaceuticals, medicated feed additives covering the revenue growth of each sub-segment from 2018 to 2030.
Argentina is expected to hold a substantial share of the veterinary medicine market during the forecast period due to an increase in the number of animal healthcare facilities and the presence of untapped opportunities. Furthermore, increasing pet adoption and ownership have contributed to market growth.
For instance, 86% of households in Argentina have at least one pet, mostly a dog or cat. Market players are consistently investing in R&D efforts to introduce efficient medicines. In addition, they are expanding their global footprints by implementing a variety of market strategies, such as joint ventures, partnerships, and sales agreements.
For instance, to commercialize the Circo/MycoGard vaccine in the country and region, the Argentine laboratory Vetanco formed a commercial partnership with a U.S. company—Pharm gate Animal Health—in April 2021. The vaccine protects pigs against PCV-2 and Mycoplasma hyopneumoniae.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina veterinary medicine market , including forecasts for subscribers. This country databook contains high-level insights into Argentina veterinary medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account